ARTICLE | Clinical News
tgAAVCF: Phase IIb ongoing
June 28, 2004 7:00 AM UTC
TGEN said a data monitoring committee recommended continuing the company's double-blind, placebo-controlled Phase IIb trial in 100 patients. The recommendation was based on an interim analysis of data...